Glucocorticoid effects on chondrogenesis, differentiation and apoptosis in the murine ATDC5 chondrocyte cell line
- PMID: 12475381
- DOI: 10.1677/joe.0.1750705
Glucocorticoid effects on chondrogenesis, differentiation and apoptosis in the murine ATDC5 chondrocyte cell line
Abstract
Glucocorticoids (GC) are used extensively in children and may cause growth retardation, which is in part due to the direct effects of GC on the growth plate. We characterised the ATDC5 chondrocyte cell line, which mimics the in vivo process of longitudinal bone growth, to examine the effects of dexamethasone (Dex) and prednisolone (Pred) during two key time points in the chondrocyte life cycle - chondrogenesis and terminal differentiation. Additionally, we studied the potential for recovery following Dex exposure. During chondrogenesis, Dex and Pred exposure at 10(-8) M, 10(-7) M and 10(-6) M resulted in a significant mean reduction in cell number (28% vs 20%), cell proliferation (27% vs 24%) and proteoglycan synthesis (47% vs 43%) and increased alkaline phosphatase (ALP) activity (106% vs 62%), whereas the incidence of apoptosis was unaltered. Minimal effects were noted during terminal differentiation with both GC although all concentrations of Dex lowered apoptotic cell number. To assess catch-up growth the cells were incubated for a total of 14 days which included 1, 3, 7, 10 or 14 days exposure to 10(-6) M Dex, prior to the recovery period. Recovery of proteoglycan synthesis was irreversibly impaired following just one day exposure to Dex. Although cell number showed a similar pattern, significant impairment was only achieved following 14 days exposure. Irreversible changes in ALP activity were only noticed following 10 days exposure to Dex. In conclusion, GC have maximal effects during chondrogenesis; Dex is more potent than Pred and cells exposed to Dex recover but this may be restricted due to differential effects of GC on specific chondrocyte phenotypes.
Similar articles
-
Dexamethasone: chondroprotective corticosteroid or catabolic killer?Eur Cell Mater. 2019 Nov 22;38:246-263. doi: 10.22203/eCM.v038a17. Eur Cell Mater. 2019. PMID: 31755076 Free PMC article. Review.
-
The growth plate sparing effects of the selective glucocorticoid receptor modulator, AL-438.Mol Cell Endocrinol. 2007 Jan 29;264(1-2):164-70. doi: 10.1016/j.mce.2006.11.006. Epub 2006 Dec 19. Mol Cell Endocrinol. 2007. PMID: 17182172
-
Dexamethasone inhibits insulin-induced chondrogenesis of ATDC5 cells by preventing PI3K-Akt signaling and DNA binding of Runx2.J Cell Biochem. 2004 Oct 1;93(2):374-83. doi: 10.1002/jcb.20192. J Cell Biochem. 2004. PMID: 15368363
-
Dexamethasone inhibits and thyroid hormone promotes differentiation of mouse chondrogenic ATDC5 cells.Bone. 2002 Oct;31(4):457-64. doi: 10.1016/s8756-3282(02)00855-4. Bone. 2002. PMID: 12398940
-
Chondrogenesis from stem cell recruitment to hypertrophy by a tripotential mesoblastic cell line.Osteoarthritis Cartilage. 2001;9 Suppl A:S85-90. doi: 10.1053/joca.2001.0449. Osteoarthritis Cartilage. 2001. PMID: 11680694 Review. No abstract available.
Cited by
-
Zwitterionic polymer-dexamethasone conjugates penetrate and protect cartilage from inflammation.Mater Today Bio. 2024 Apr 10;26:101049. doi: 10.1016/j.mtbio.2024.101049. eCollection 2024 Jun. Mater Today Bio. 2024. PMID: 38654933 Free PMC article.
-
GH therapy in children with juvenile idiopathic arthritis: a four-decade review.Clin Pediatr Endocrinol. 2024;33(1):1-11. doi: 10.1297/cpe.2023-0036. Epub 2023 Dec 2. Clin Pediatr Endocrinol. 2024. PMID: 38299178 Free PMC article. Review.
-
Bone Health in Children with Rheumatic Disorders: Focus on Molecular Mechanisms, Diagnosis, and Management.Int J Mol Sci. 2022 May 20;23(10):5725. doi: 10.3390/ijms23105725. Int J Mol Sci. 2022. PMID: 35628529 Free PMC article. Review.
-
Growth and puberty in children with juvenile idiopathic arthritis.Pediatr Rheumatol Online J. 2021 Mar 12;19(1):28. doi: 10.1186/s12969-021-00521-5. Pediatr Rheumatol Online J. 2021. PMID: 33712046 Free PMC article. Review.
-
Effect of dexamethasone as osteogenic supplementation in in vitro osteogenic differentiation of stem cells from human exfoliated deciduous teeth.J Mater Sci Mater Med. 2021 Jan 19;32(1):1. doi: 10.1007/s10856-020-06475-6. J Mater Sci Mater Med. 2021. PMID: 33469820 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous